FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michel Clanet

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Geographic Areas

France

Physiology

Anatomy

Brain

Procedures

Co-author Network

Publications

TOP 3
Stephan Klebe; Elodie Lejeune; Cecilia Mancini; Jean-Michel Mayer; Elisabeth Ollagnon; Jean-Michel Rozet; Jérôme de Seze; Guilhem Sole; Giovanni Stevanin; Mathieu Anheim; Alexis Brice; Alfredo Brusco; Philippe Busson; Cécile Cazeneuve; Georges Challe; Perrine Charles; Patrick F Chinnery; Michel Clanet; Julien Cottineau; Christel Depienne; Alain Destée; Hélène Dollfus; Estelle Fedirko; Xavier Ferrer; Bertrand Fontaine; Sylvie Gerber; Josseline Kaplan; Alexandra Durr
Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.
Julien Guillotreau; Bernard Malavaud; Philippe Marque; Jalesh N Panicker; Pascal Rischmann; Mathieu Roumiguié; Frédérique Viala; Evelyne Castel-Lacanal; Michel Clanet; xavier game
Prospective evaluation of laparoscopic assisted cystectomy and ileal conduit in advanced multiple sclerosis.
Ludwig Kappos; David Bates; Michel Clanet; David B Clifford; Gilles Edan; Mefkûre Eraksoy; Antonio Garcia-Merino; Ralf Gold; Nikolaos Grigoriadis; Hans-Peter Hartung; Stephen Hauser; Eva Havrdová; Jan Hillert; Hans H Hirsch; Reinhard Hohlfeld; Marcelo Kremenchutzky; Olivier Lyon-Caen; Eugene O Major; Ariel Miller; Paul W O'Connor; Carlo Pozzilli; Ernst W Radü; Mads Ravnborg; Takahiko Saida; Christian Sindic; Per Soelberg Sørensen; Karl Vass; Howard L Weiner; John King
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michel Clanet (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Stephan Klebe; Elodie Lejeune; Cecilia Mancini; Jean-Michel Mayer; Elisabeth Ollagnon; Jean-Michel Rozet; Jérôme de Seze; Guilhem Sole; Giovanni Stevanin; Mathieu Anheim; Alexis Brice; Alfredo Brusco; Philippe Busson; Cécile Cazeneuve; Georges Challe; Perrine Charles; Patrick F Chinnery; Michel Clanet; Julien Cottineau; Christel Depienne; Alain Destée; Hélène Dollfus; Estelle Fedirko; Xavier Ferrer; Bertrand Fontaine; Sylvie Gerber; Josseline Kaplan; Alexandra Durr
Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.
Brain : a journal of neurology 2012;135(Pt 10):2980-93.
2012: Julien Guillotreau; Bernard Malavaud; Philippe Marque; Jalesh N Panicker; Pascal Rischmann; Mathieu Roumiguié; Frédérique Viala; Evelyne Castel-Lacanal; Michel Clanet; xavier game
Prospective evaluation of laparoscopic assisted cystectomy and ileal conduit in advanced multiple sclerosis.
Urology 2012;80(4):852-7.
2011: Ludwig Kappos; David Bates; Michel Clanet; David B Clifford; Gilles Edan; Mefkûre Eraksoy; Antonio Garcia-Merino; Ralf Gold; Nikolaos Grigoriadis; Hans-Peter Hartung; Stephen Hauser; Eva Havrdová; Jan Hillert; Hans H Hirsch; Reinhard Hohlfeld; Marcelo Kremenchutzky; Olivier Lyon-Caen; Eugene O Major; Ariel Miller; Paul W O'Connor; Carlo Pozzilli; Ernst W Radü; Mads Ravnborg; Takahiko Saida; Christian Sindic; Per Soelberg Sørensen; Karl Vass; Howard L Weiner; John King
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring.
Lancet neurology 2011;10(8):745-58.
2011: Nicolas Couturier; Florence Bucciarelli; Ramil N Nurtdinov; Marc Debouverie; Christine Lebrun-Frenay; Gilles Defer; Thibault Moreau; Christian Confavreux; Sandra Vukusic; Isabelle Cournu-Rebeix; Robert H Goertsches; Uwe K Zettl; Manuel Comabella; Xavier Montalban; Peter Rieckmann; Frank Weber; Bertram Müller-Myhsok; Gilles Edan; Bertrand Fontaine; Lennart T Mars; Abdelhadi Saoudi; Jorge R Oksenberg; Michel Clanet; Roland S Liblau; David Brassat
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility.
Brain : a journal of neurology 2011;134(Pt 3):693-703.
2011: R A Rudick; Ludwig Kappos; R Philip Kinkel; Michel Clanet; J T Phillips; R M Herndon; A W Sandrock; F E Munschauer
Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(3):353-60.
2011: Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
Annals of neurology 2011;69(2):292-302.
2010: Alexandra Benouaich-Amiel; vincent lubrano; M Tafani; Emmanuelle Uro-Coste; Pierre Gantet; Jean Christophe Sol; Franck Roux; Philippe Bousquet; Anne Julian; Jean Sabatier; Michel Tremoulet; Valerie Cances-Lauwers; Marie-Bernadette Delisle; Michel Clanet; Jean Philippe Esquerré; Pierre Payoux
Evaluation of O-(2-[18F]-Fluoroethyl)-L-Tyrosine in the Diagnosis of Glioblastoma.
Archives of neurology 2010;67(3):370-2.
2010: C Sagnes-Raffy; Pierre-Antoine Gourraud; V Hannon; R Bourrel; M-A Laffontan; M-C Gaulene; F Viala; Michel Clanet
[Multiple sclerosis in Haute-Garonne: an important underestimation of case numbers].
Revue d'épidémiologie et de santé publique 2010;58(1):23-31.
2009: Nicolas Couturier; Pierre-Antoine Gourraud; Isabelle Cournu-Rebeix; Claire Gout; Florence Bucciarelli; Gilles Edan; Marie-Claude Babron; Françoise Clerget-Darpoux; Michel Clanet; Bertrand Fontaine; David Brassat
IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients.
European journal of human genetics : EJHG 2009;17(6):844-7.
2009: Eliane Graulières; Jean-Albert Lotterie; Emmanuelle Cassol; Angélique Gerdelat; Michel Clanet; Isabelle Berry
Relevance of the skewness index in DTI exploration of multiple sclerosis.
Magma (New York, N.Y.) 2009;22(2):89-100.
2008: Nicolas Couturier; Jacques P Zappulla; Valérie Lauwers-Cances; Emmanuelle Uro-Coste; Marie-Bernadette Delisle; Michel Clanet; Lisette Montagne; Paul Van der Valk; Lars Bö; Roland S Liblau
Mast cell transcripts are increased within and outside multiple sclerosis lesions.
Journal of neuroimmunology 2008;195(1-2):176-85.
2008: Bénédicte Puissant-Lubrano; Frédérique Viala; Peter Winterton; Michel Abbal; Michel Clanet; Antoine Blancher
Thymic output and peripheral T lymphocyte subsets in relapsing--remitting multiple sclerosis patients treated or not by IFN-beta.
Journal of neuroimmunology 2008;193(1-2):188-94.
2007: Christel Renoux; Sandra Vukusic; Yann Mikaeloff; Gilles Edan; Michel Clanet; Bénédicte Dubois; Marc Debouverie; Bruno Brochet; Christine Lebrun-Frenay; Jean Pelletier; Thibault Moreau; Catherine Lubetzki; Patrick Vermersch; Etienne Roullet; Laurent Magy; Marc Tardieu; Samy Suissa; Christian Confavreux
Natural history of multiple sclerosis with childhood onset.
The New England journal of medicine 2007;356(25):2603-13.
2006: Mourad Naïmi; Sylvie Bannwarth; Vincent Procaccio; Jean Pouget; Claude Desnuelle; Jean-François Pellissier; Agnès Rötig; Arnold Munnich; Patrick Calvas; Christian Richelme; Philippe Jonveaux; Giovanni Castelnovo; Mariella Simon; Melvin Simon; Michel Clanet; Douglas C Wallace; Véronique Paquis-Flucklinger
Molecular analysis of ANT1, TWINKLE and POLG in patients with multiple deletions or depletion of mitochondrial DNA by a dHPLC-based assay.
European journal of human genetics : EJHG 2006;14(8):917-22.
2006: Michel Clanet; Reinhard Hohlfeld
MS treatment optimization: report from the 21st ETRIMS/10th ACTRIMS Congress, 28 September-1 October 2005, Thessaloniki, Greece.
International MS journal / MS Forum 2006;13(1):13-5.
2005: Michel Clanet
Motivating MS patients: the Annual Convention 2005 of the MS Forum, 22 May 2005, St Julians, Malta.
International MS journal / MS Forum 2005;12(3):109.
2005: Michel Clanet
Therapeutic developments in MS: report from the 57th Annual Meeting of the American Academy of Neurology (AAN), 9-15 April 2004, Miami, Florida, USA.
International MS journal / MS Forum 2005;12(2):69-70.
2005: Ludwig Kappos; Michel Clanet; M Sandberg-Wollheim; Ernst-Wilhelm Radue; HP Hartung; R Hohlfeld; J Xu; D Bennett; Alfred W Sandrock; S Goelz
Neutralizing antibodies and efficacy of interferon beta-1a: a 4-year controlled study.
Neurology 2005;65(1):40-7.
2005: Christian Confavreux; Sandra Vukusic; T Arbizu; Bruno Brochet; Michel Clanet; Gilles Edan; L Kappos; Samy Suissa
[Sclerotic plaques and hepatitis B vaccination in adults: the situation in 2004. Response].
Revue neurologique 2005;161(6-7):644-6; author reply 646-7.
2005: Bruno Stankoff; Emmanuelle Waubant; Christian Confavreux; Gilles Edan; Marc Debouverie; Lucien Rumbach; Thibault Moreau; J Pelletier; Catherine Lubetzki; Michel Clanet
Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
Neurology 2005;64(7):1139-43.
2005: Martin Hardmeier; Stefan Wagenpfeil; Peter Freitag; E Fisher; Richard A Rudick; MF Kooijmans; Michel Clanet; Ernst-Wilhelm Radue; Ludwig Kappos
Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a.
Neurology 2005;64(2):236-40.
2005: Françoise Bergametti; Christian Denier; Pierre Labauge; Minh Arnoult; Sergio Boetto; Michel Clanet; Philippe Coubes; Bernard Echenne; R Ibrahim; B Irthum; G Jacquet; M Lonjon; J J Moreau; Jean-Philippe Neau; Fabrice Parker; M Tremoulet; Elisabeth Tournier-Lasserve
Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations.
American journal of human genetics 2005;76(1):42-51.
2004: Shannon J Kenealy; Marie-Claude Babron; Yuki Bradford; Nathalie Schnetz-Boutaud; Jonathan L Haines; Jacqueline B Rimmler; Silke Schmidt; Margaret Pericak-Vance; Lisa F Barcellos; Robin R Lincoln; Jorge R Oksenberg; Stephen L Hauser; Michel Clanet; David Brassat; G Edan; Jacqueline Yaouanq; Gilbert Semana; Isabelle Cournu-Rebeix; O Lyon-Caen; Bertrand Fontaine
A second-generation genomic screen for multiple sclerosis.
American journal of human genetics 2004;75(6):1070-8.
2004: Axel Petzold; David Brassat; P Mas; Konrad Rejdak; Geoff Keir; Gavin Giovannoni; Edward J Thompson; Michel Clanet
Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(3):281-3.
2004: Pierre Delobel; David Brassat; Marie Danjoux; Jean-Albert Lotterie; Muriel Irsutti-Fjørtoft; Michel Clanet; Guy Laurent
Granulomatous angiitis of the central nervous system revealing Hodgkin's disease.
Journal of neurology 2004;251(5):611-2.
2004: Emmanuelle Cassol; Jean-Philippe Ranjeva; Danielle Ibarrola; Claude Mékies; Claude Manelfe; Michel Clanet; Isabelle Berry
Diffusion tensor imaging in multiple sclerosis: a tool for monitoring changes in normal-appearing white matter.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(2):188-96.
2004: Michel Clanet; Ludwig Kappos; HP Hartung; R Hohlfeld
Interferon beta-1a in relapsing multiple sclerosis: four-year extension of the European IFNbeta-1a Dose-Comparison Study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(2):139-44.
2004: Pierre Delobel; David Brassat; Marie B Delisle; Francesco Scaravilli; Michel Clanet
Progressive multifocal leukoencephalopathy in an HIV patient with normal CD4 T-cell count and magnetic resonance imaging.
AIDS (London, England) 2004;18(4):702-4.
2004: Margaret Pericak-Vance; Jacqueline B Rimmler; Jonathan L Haines; Melissa E Garcia; Jorge R Oksenberg; Lisa F Barcellos; Robin R Lincoln; Stephen L Hauser; Isabelle Cournu-Rebeix; Ariele Azoulay-Cayla; Olivier Lyon-Caen; Bertrand Fontaine; Emmanuelle Duhamel; helene coppin; David Brassat; Marie-Paule Roth; Michel Clanet; Mehdi Alizadeh; Jacqueline Yaouanq; Erwann Quelvennec; Gilbert Semana; Gilles Edan; Marie-Claude Babron; Emmanuelle Genin; Françoise Clerget-Darpoux
Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative study.
Neurogenetics 2004;5(1):45-8.
2004: Hélène Coppin; M-T Ribouchon; Bertrand Fontaine; Gilles Edan; Michel Clanet; Marie-Paule Roth
A vulnerability locus to multiple sclerosis maps to 7p15 in a region syntenic to an EAE locus in the rat.
Genes and immunity 2004;5(1):72-5.
2003: Michel Clanet; M Cucheratt
Interferons in relapsing remitting MS: a systematic review comments on a meta-analysis.
International MS journal / MS Forum 2003;10(4):134-5.
2003: Martin Hardmeier; Stefan Wagenpfeil; Peter Freitag; Elizabeth Fisher; Richard A Rudick; Mariska Kooijmans-Coutinho; Michel Clanet; Ernst-Wilhelm Radue; Ludwig Kappos
Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis.
Archives of neurology 2003;60(12):1736-9.
2003: Mehdi Alizadeh; Emmanuelle Génin; Marie-Claude Babron; Brigitte Birebent; Isabelle Cournu-Rebeix; Jacqueline Yaouanq; Stéphane Dréano; Stephen Sawcer; Alastair Compston; Michel Clanet; Gilles Edan; Bertrand Fontaine; Françoise Clerget-Darpoux; Gilbert Semana
Genetic analysis of multiple sclerosis in Europeans: French data.
Journal of neuroimmunology 2003;143(1-2):74-8.
2003: Isabelle Cournu-Rebeix; Emmanuelle Génin; Gaëtan Lesca; Ariele Azoulay-Cayla; N Tubridy; E Noé; Michel Clanet; Gilles Edan; Françoise Clerget-Darpoux; G Sémana; Bertrand Fontaine
Intercellular adhesion molecule-1: a protective haplotype against multiple sclerosis.
Genes and immunity 2003;4(7):518-23.
2003: Mehdi Alizadeh; Marie-Claude Babron; Brigitte Birebent; Fumihiko MATSUDA; Erwann Quelvennec; Roland S Liblau; Isabelle Cournu-Rebeix; Patricia Momigliano-Richiardi; Jorge Sequeiros; Jacqueline Yaouanq; Emmanuelle Genin; Alexandre Vasilescu; Héloise Bougerie; Maria Trojano; Berta Martins Silva; Patrícia Maciel; Françoise Clerget-Darpoux; Michel Clanet; Gilles Edan; Bertrand Fontaine; Gilbert Semana
Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients.
Annals of neurology 2003;54(1):119-22.
2003: Michel Clanet; Emmanuelle Cassol; Claude Manelfe; Isabelle Berry
Clinical-MRI correlations in the secondary progressive phase of MS: lessons from the treatment trials.
Journal of the neurological sciences 2003;206(2):139-44.
2002: Michel Clanet; Ernst-Wilhelm Radue; Ludwig Kappos; HP Hartung; R Hohlfeld; M Sandberg-Wollheim; Mariska Kooijmans-Coutinho; EC Tsao; Alfred W Sandrock
A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS.
Neurology 2002;59(10):1507-17.
2002: David Brassat; Christian Recher; Emmanuelle Waubant; Emmanuelle Le Page; Françoise Rigal-Huguet; Guy Laurent; Gilles Edan; Michel Clanet
Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS.
Neurology 2002;59(6):954-5.
2002: Pierre Labauge; L O Amer; Marion Simonetta-Moreau; F Attané; C Tannier; Michel Clanet; Giovanni Castelnovo; I An-Gourfinkel; Yves Agid; Alexis Brice; Anne Ducros; Eric LeGuern
Absence of linkage to 8q24 in a European family with familial adult myoclonic epilepsy (FAME).
Neurology 2002;58(6):941-4.
2001: Michel Clanet; C G Pigois
[Imparting the diagnosis and educating patients with multiple sclerosis].
Revue neurologique 2001;157(8-9 Pt 2):1153-6.
2001: Isabelle Berry; Emmanuelle Cassol; Danielle Ibarrola; Claude Manelfe; Michel Clanet
[New MRI techniques in multiple sclerosis].
Revue neurologique 2001;157(8-9 Pt 1):769-76.
2001: Pierre Labauge; Laurent Brunereau; Philippe Coubes; Michel Clanet; C Tannier; Sophie Laberge-Le Couteulx; Claude Lévy
Appearance of new lesions in two nonfamilial cerebral cavernoma patients.
European neurology 2001;45(2):83-8.
2000: Hélène Coppin; M T Ribouchon; P Bausero; Bernard Pessac; Bertrand Fontaine; Gilbert Semana; Michel Clanet; Marie-Paule Roth
No evidence for transmission disequilibrium between a new marker at the myelin basic protein locus and multiple sclerosis in French patients.
Genes and immunity 2000;1(8):478-82.
2000: Christine Brefel-Courbon; Marion Simonetta-Moreau; C Moré; Olivier Rascol; Michel Clanet; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis.
Clinical neuropharmacology 2000;23(4):203-7.
2000: Michel Clanet; D Brassat
The management of multiple sclerosis patients.
Current opinion in neurology 2000;13(3):263-70.
2000: J Reboul; Caroline Mertens; F Levillayer; S Eichenbaum-Voline; T Vilkoren; I Cournu; Marie-Claude Babron; Olivier Lyon-Caen; Françoise Clerget-Darpoux; Gilles Edan; Michel Clanet; Michel Brahic; Jean-François Bureau; Bertrand Fontaine; Roland S Liblau
Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics Group.
Journal of neuroimmunology 2000;102(1):107-12.
1999: Claude Manelfe; Michel Clanet; Isabelle Berry
[Case no.1. Diagnosis: Balo concentric sclerosis].
Journal de radiologie 1999;80(12):1700-2.
1999: Bertrand Fontaine; I Cournu; I Arnaud; Marie-Claude Babron; S Eichenbaum-Voline; Jorge R Oksenberg; Margaret Pericak-Vance; Jonathan L Haines; G Semama; Roland S Liblau; Olivier Lyon-Caen; Françoise Clerget-Darpoux; Michel Clanet; S L Hauser
Chromosome 17q22-q24 and multiple sclerosis genetic susceptibility. American-French Multiple Sclerosis Genetic Group.
Genes and immunity 1999;1(2):149-50.
1999: David Brassat; Michel Clanet
[Treatment of symptoms and relapses of multiple sclerosis].
La Revue du praticien 1999;49(17):1877-81.
1999: Jean-François Albucher; C Vuillemin-Azaïs; Claude Manelfe; Michel Clanet; Bernard Guiraud-Chaumeil; François Chollet
Cerebral thrombophlebitis in three patients with probable multiple sclerosis. Role of lumbar puncture or intravenous corticosteroid treatment.
Cerebrovascular diseases (Basel, Switzerland) 1999;9(5):298-303.
1999: David Brassat; C Azais-Vuillemin; Jacqueline Yaouanq; Gilbert Semana; J Reboul; I Cournu; Caroline Mertens; Gilles Edan; Olivier Lyon-Caen; Michel Clanet; Bertrand Fontaine
Familial factors influence disability in MS multiplex families. French Multiple Sclerosis Genetics Group.
Neurology 1999;52(8):1632-6.
1999: Marie-Paule Roth; C Viratelle; L Dolbois; M Delverdier; Nicolas Borot; Lucette Pelletier; Philippe Druet; Michel Clanet; Hélène Coppin
A genome-wide search identifies two susceptibility loci for experimental autoimmune encephalomyelitis on rat chromosomes 4 and 10.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(4):1917-22.
1998: Isabelle Berry; Jean-Philippe Ranjeva; Claude Manelfe; Michel Clanet
[MRI visualization of multiple sclerosis lesions].
Revue neurologique 1998;154(8-9):607-17.
1998: Caroline Mertens; David Brassat; J Reboul; S Eichenbaum-Voline; C Vuillemin-Azais; I Cournu; Marie-Claude Babron; Gilbert Semana; Gilles Edan; Michel Clanet; Françoise Clerget-Darpoux; Anne Baron-Van Evercooren; Olivier Lyon-Caen; Roland S Liblau; Bertrand Fontaine
A systematic study of oligodendrocyte growth factors as candidates for genetic susceptibility to MS. French Multiple Sclerosis Genetics Group.
Neurology 1998;51(3):748-53.
1998: Michel Clanet; Isabelle Berry
Magnetic resonance imaging in multiple sclerosis.
Current opinion in neurology 1998;11(4):299-303.
1998: Emmanuelle Waubant; M B Delisle; A Bonafé; F Gray; Michel Clanet
Cervical cord glioma in an HIV-positive patient.
European neurology 1998;39(1):58-60.
1997: Emmanuelle Waubant; Marion Simonetta-Moreau; Michel Clanet; Isabelle Berry; A Bonafé
Left arm monoballism as a relapse in multiple sclerosis.
Movement disorders : official journal of the Movement Disorder Society 1997;12(6):1091-2.
1997: Emmanuelle Waubant; Claude Manelfe; A Bonafé; Isabelle Berry; Michel Clanet
MRI of intramedullary sarcoidosis: follow-up of a case.
Neuroradiology 1997;39(5):357-60.
1997: Gilles Edan; D Miller; Michel Clanet; Christian Confavreux; Olivier Lyon-Caen; C Lubetzki; Bruno Brochet; Isabelle Berry; Y Rolland; J C Froment; Emmanuel Alain Cabanis; Marie-Thérèse Iba-Zizen; J M Gandon; H M Lai; Ivan Moseley; O Sabouraud
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.
Journal of neurology, neurosurgery, and psychiatry 1997;62(2):112-8.
1996: Jean-François Albucher; Pierre Carles; J Giron; Emmanuelle Waubant; Bernard Guiraud-Chaumeil; François Chollet; Michel Clanet
[Ischemic cerebrovascular complications in Rendu-Osler disease: a case].
Revue neurologique 1996;152(4):283-7.
1995: Olivier Rascol; Timothy Hain; C Brefel; M Benazet; Michel Clanet; Jean-Louis Montastruc
Antivertigo medications and drug-induced vertigo. A pharmacological review.
Drugs 1995;50(5):777-91.
1995: Olivier Rascol; Umberto Sabatini; Nelly Fabre; Jean-Michel Senard; M Simonetta-Moreau; Jean-Louis Montastruc; Michel Clanet; A Rascol
Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1995;10(2):163-70.
1994: Michel Clanet; A Bonafé; M J Estève-Fraysse; Bernard Fraysse
[Vertigo in non-vascular diseases of the central nervous system].
La Revue du praticien 1994;44(3):328-35.
1989: François Chollet; Pierre Celsis; Michel Clanet; Bernard Guiraud-Chaumeil; A Rascol; J P Marc-Vergnes
SPECT study of cerebral blood flow reactivity after acetazolamide in patients with transient ischemic attacks.
Stroke; a journal of cerebral circulation 1989;20(4):458-64.
1986: J P Marc-Vergnes; Pierre Celsis; Michel Clanet; François Chollet; B Guiraud; Gérard Viallard; A Rascol
[Measurement of cerebral blood flow. Technical improvements and practical value in the evaluation of the ischemic risk and prognosis in neurological lesions].
Agressologie: revue internationale de physio-biologie et de pharmacologie appliquées aux effets de l'agression 1986;27(7):569-71.
1986: Michel Clanet; Michel Abbal; M Munoz; Jean Tkaczuk; A Rascol; Bernard Guiraud-Chaumeil
[Analysis of the cerebrospinal fluid by isoelectrofocusing on agarose in multiple sclerosis].
Revue neurologique 1986;142(8-9):677-82.
1982: A Rascol; Jean-Louis Montastruc; Bernard Guiraud-Chaumeil; Michel Clanet
[Bromocriptine as the 1st treatment of Parkinson's disease. Long term results].
Revue neurologique 1982;138(5):401-8.
1982: A Rascol; Michel Clanet; Claude Manelfe; B Guiraud; A Bonafe
Pure motor hemiplegia: CT study of 30 cases.
Stroke; a journal of cerebral circulation 1982;13(1):11-7.
1982: Bernard Guiraud-Chaumeil; A Rascol; J David; B Boneu; Michel Clanet; R Bierme
[Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial].
Revue neurologique 1982;138(5):367-85.
1981: A Rascol; Michel Clanet; Jean-Louis Montastruc; W Delage; Bernard Guiraud-Chaumeil
L5H tryptophan in the cerebellar syndrome treatment.
Biomedicine / [publiée pour l'A.A.I.C.I.G.] 1981;35(4):112-3.
1981: Jean-Louis Montastruc; A J Puech; Michel Clanet; Bernard Guiraud-Chaumeil; A Rascol
[Yohimbine in treatment of Parkinson's disease. Preliminary results (author's transl)].
La Nouvelle presse médicale 1981;10(16):1331-2.
1981: R Durroux; L Benouaich; H Bouissou; M Mansat; Michel Clanet
[Tenosynovitis of the carpal canal and amyloid deposits in patients with chronic renal insufficiency undergoing hemodialysis].
La Nouvelle presse médicale 1981;10(1):45.
1981: Michel Clanet; M Mansat; R Durroux; M F Testut; B Guiraud; A Rascol; J Conte
[Carpal tunnel syndrome, amyloid tenosynovitis and periodic hemodialysis].
Revue neurologique 1981;137(10):613-24.
1980: A Rascol; J Cambier; B Guiraud; Claude Manelfe; J David; Michel Clanet
[Cerebral ischemic accidents during migraine attacks. A report on "complicated migraine"].
Revue neurologique 1980;135(12):867-84.